Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development
Vaccines · 13.08.2025 · 13 (8) · 856
DOI: 10.3390/vaccines13080856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 13.08.2025. Verfasst von Mohammad Enamul Hoque Kayesh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barish…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tokyo Metropolitan Government, Japan Agency for Medical Research and Development, Japanese Agency for Medical Research and Development.
Abstract (Originalsprache)
CHIKV is a re-emerging mosquito-borne arthritogenic alphavirus associated with large outbreaks and severe joint pain, and it poses a growing global health threat. Toll-like receptors (TLRs), as key pattern recognition receptors, detect viral components and initiate antiviral immune responses. Increasing evidence highlights the role of TLR signaling in shaping CHIKV infection outcomes, though its precise contribution remains unclear. CHIKV has developed mechanisms to evade host innate immune surveillance, promoting viral replication. TLR agonists show promise as vaccine adjuvants by enhancing immune responses. In this review, we summarize current insights into TLR-mediated immunity during CHIKV infection, the virus’s innate immune evasion strategies, and the potential of TLR agonists in improving vaccine efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal 8210, Bangladesh.
- Transboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, Japan.
- Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
ORCID-Profile: Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara
Förderung
- Tokyo Metropolitan Government
- Japan Agency for Medical Research and Development
- Japanese Agency for Medical Research and Development
Zitieren
APA
Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2025). Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development. Vaccines, 13(8), 856. https://doi.org/10.3390/vaccines13080856
Vancouver
Kayesh MEH, Kohara M, Tsukiyama-Kohara K. Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development. Vaccines. 2025;13(8):856. doi:10.3390/vaccines13080856
BibTeX
@article{Kayesh2025,
author = {Kayesh, Mohammad Enamul Hoque and Kohara, Michinori and Tsukiyama-Kohara, Kyoko},
title = {Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {8},
pages = {856},
doi = {10.3390/vaccines13080856}
}
EUVIMED